Research records indexed for Somatropin
This page carries 12 of the 440 records that the literature query returned for Somatropin, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 428 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is Somatropin.
Indexed records
| Record | Year | Study type | Model | n as stated | What it reported |
|---|---|---|---|---|---|
| Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study pmid:35405011 | 2022 | Clinical Trial, Phase III, Research Support, Non-U.S. Gov't | human trial | Not stated | Indexed as clinical trial, phase iii, research support, non-u.s. gov't. study model from MeSH "Humans" with publication type "clinical trial, phase iii". subject headings: Dwarfism, Pituitary; Growth Disorders; Growth Hormone; Human Growth Hormone; Recombinant Proteins. |
| Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study pmid:35417909 | 2022 | Clinical Trial, Phase III, research-article | human trial | Not stated | Indexed as clinical trial, phase iii, research-article. study model from MeSH "Humans" with publication type "clinical trial, phase iii". subject headings: Dwarfism, Pituitary; Pain; Growth Disorders; Growth Hormone; Human Growth Hormone. |
| Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results pmid:35428884 | 2022 | Clinical Trial, Phase III, Research Support, Non-U.S. Gov't | human trial | Not stated | Indexed as clinical trial, phase iii, research support, non-u.s. gov't. study model from MeSH "Humans" with publication type "clinical trial, phase iii". subject headings: Dwarfism, Pituitary; Growth Disorders; Growth Hormone; Human Growth Hormone; Body Height. |
| Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt Trial pmid:35263755 | 2022 | Clinical Trial, Phase III, research-article | human trial | Not stated | Indexed as clinical trial, phase iii, research-article. study model from MeSH "Humans" with publication type "clinical trial, phase iii". subject headings: Dwarfism, Pituitary; Growth Disorders; Growth Hormone; Human Growth Hormone; Insulin-Like Growth Factor I. |
| Lonapegsomatropin: Pediatric First Approval pmid:34709591 | 2022 | Review | other | Not stated | Indexed as review. study model from MeSH "Humans" with no interventional publication type. subject headings: Growth Hormone; Human Growth Hormone; Injections, Subcutaneous. |
| Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial pmid:34272849 | 2021 | Clinical Trial, Phase III, Research Support, Non-U.S. Gov't | human trial | Not stated | Indexed as clinical trial, phase iii, research support, non-u.s. gov't. study model from MeSH "Humans" with publication type "clinical trial, phase iii". subject headings: Dwarfism, Pituitary; Human Growth Hormone; Insulin-Like Growth Factor I; Insulin-Like Growth Factor Binding Protein 3; Prognosis. |
| Long-term efficacy and safety of two doses of Norditropin<sup>®</sup> (somatropin) in Noonan syndrome: a 4-year randomized, double-blind, multicenter trial in Japanese patients pmid:32269181 | 2020 | Multicenter Study, Randomized Controlled Trial | human trial | Not stated | Indexed as multicenter study, randomized controlled trial. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Noonan Syndrome; Growth Disorders; Human Growth Hormone; Body Height; Follow-Up Studies. |
| Efficacy and safety of two doses of Norditropin<sup>®</sup> (somatropin) in short stature due to Noonan syndrome: a 2-year randomized, double-blind, multicenter trial in Japanese patients pmid:29109363 | 2018 | Multicenter Study, Randomized Controlled Trial | human trial | Not stated | Indexed as multicenter study, randomized controlled trial. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Noonan Syndrome; Human Growth Hormone; Body Height; Drug Administration Schedule; Follow-Up Studies. |
| Availability and quality of illegitimate somatropin products obtained from the Internet pmid:27888454 | 2017 | Journal Article | other | Not stated | Indexed as journal article. study model from MeSH "Humans" with no interventional publication type. subject headings: Human Growth Hormone; Internet; Prescription Drugs; Counterfeit Drugs; Pharmaceutical Services, Online. |
| Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study pmid:24300782 | 2014 | Research Support, Non-U.S. Gov't, Multicenter Study | human trial | Not stated | Indexed as research support, non-u.s. gov't, multicenter study. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Lower Extremity; Upper Extremity; Spinal Muscular Atrophies Of Childhood; Human Growth Hormone; Respiratory Function Tests. |
| Fully traceable absolute protein quantification of somatropin that allows independent comparison of somatropin standards pmid:19729472 | 2009 | Comparative Study, Research Support, Non-U.S. Gov't | other | Not stated | Indexed as comparative study, research support, non-u.s. gov't. study model from MeSH "Humans" with no interventional publication type. subject headings: Human Growth Hormone; Peptides; Recombinant Proteins; Sensitivity And Specificity; Mass Spectrometry. |
| PEGylation of somatropin (recombinant human growth hormone): impact on its clearance in humans pmid:18802875 | 2008 | Journal Article | other | Not stated | Indexed as journal article. study model from MeSH "Humans" with no interventional publication type. subject headings: Polyethylene Glycols; Human Growth Hormone; Drug Carriers; Metabolic Clearance Rate. |
Where this page sits
Compound page: Somatropin. Class: Growth factors and growth hormone-derived compounds.
Retrieved 2026-10-12.
Sources
- Drugs@FDA application register query for this compound, 5 application(s) returned: BLA020280, BLA021148, BLA019774, BLA019640, BLA021426. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:somatropin
- The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. The New England journal of medicine (1989). pmid:2687691
- GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. The Journal of clinical endocrinology and metabolism (2013). pmid:23543664
- Effects of recombinant human growth hormone on donor-site healing in severely burned children. Annals of surgery (1990). pmid:2121109
- Effects of short term administration of recombinant human growth hormone to elderly people. The Journal of clinical endocrinology and metabolism (1990). pmid:2298863
- Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Annals of internal medicine (1996). pmid:8967667
- The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. The Journal of clinical endocrinology and metabolism (1999). pmid:10443645
- Long-term safety of recombinant human growth hormone in children. The Journal of clinical endocrinology and metabolism (2010). pmid:19906787
- Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Pharmaceutical research (1996). pmid:8899836
- Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. Journal of pharmaceutical sciences (1998). pmid:10189266
On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.